Tag Archives: Suicide

Memorial Day 2010: Psychiatric drugs triggering deaths of U.S. soldiers treated for PTSD

Andrew Tighman, writing in the Marine Corps Times, recently described the investigation of Fred A. Baughman Jr., M.D. into the deaths of military personnel taking multiple psychotropic medications. Baughman was alerted to a series of soldier deaths upon reading a May 2008 article in the Charleston [WV] Gazette titled “Vets Taking Post Traumatic Stress Disorder Drugs Die in Sleep.” Baughman, a retired neurologist known previously for his criticism of medication treatments of ADHD and other mental health disorders, suspected that the reported cases could be part of a much larger problem.

An exceptional article from psychiatrist Peter Breggin: Huffington Post – Our Psychiatric Civilization

It has been a routine week in my clinical and forensic practice. I evaluated a malpractice case involving a woman on the West Coast whose family doctor from a decade earlier kept prescribing Prozac to her for ten years without ever seeing her again. When she ran into emotional difficulty, she called this doctor who simply raised the dose and added a new drug, still without seeing her for a decade.

Earth Times: Neurologist Fred Baughman—Vets Sudden Deaths Due to Antidepressant & Antipsychotic Drugs

Fred A. Baughman Jr., MD today announced the results of his research into the “series” of veterans’ deaths acknowledged by the Surgeon General of the Army. Upon reading the May 24, 2008, Charleston (WV) Gazette article “Vets Taking Post Traumatic Stress Disorder Drugs Die in Sleep,” Baughman began to investigate why these reported deaths were “different.” And, why they were likely, the “tip of an iceberg.”

Does anyone else think this is outrageous? “Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks”

It was established years ago that Paxil carries a risk of suicide in children and teens, but GlaxoSmithKline (GSK) has for the last 18 months been conducting a study of the antidepressant in kids as young as seven — in Japan. It’s not clear why the company would want to draw more attention to its already controversial pill, but it appears as if GSK might be hoping to see a reduced suicide risk in a small population of users — a result the company could use to cast doubt on the Paxil-equals-teen-suicide meme that dominates discussion of the drug.